Envista Holdings Corporation (NVST) Institutional Ownership & Insider Trading

381 institutions reported holding Envista Holdings Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 3 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

NVSTEnvista Holdings CorporationFollow NVST — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 3.8B
P/E TTM: 40.7
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

381 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	381	190	+3.0%	133	33	117	44
Mar 26	385	178	-2.8%	122	79	106	25
Dec 25	329	186	-3.7%	106	44	103	30
Sep 25	301	191	-3.1%	91	46	96	22
Jun 25	279	197	+1.5%	83	34	106	37
Mar 25	285	193	-0.1%	101	39	80	33
Dec 24	284	195	-3.5%	71	20	107	36
Sep 24	290	190	-5.0%	93	37	96	44

Envista Holdings Corporation — questions

Who owns Envista Holdings Corporation stock?: 381 institutions reported Envista Holdings Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.5%), ARIEL INVESTMENTS, LLC (6.1%), DIMENSIONAL FUND ADVISORS LP (6.0%).
Are Envista Holdings Corporation insiders buying or selling?: 3 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Envista Holdings Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.